A few days ago, the China Chemical Pharmaceutical Industry Association (CPIA) officially announced the latest group standard of "Pharmaceutical Industry Compliance Management Practices". The "Pharmaceutical Industry Compliance Management Regulations" covers the areas of anti-commercial bribery, anti-monopoly, finance and taxation, product promotion, centralized procurement, environment, health and safety, adverse reaction reports, data compliance, and network security for companies in the pharmaceutical industry. Carrying out a comprehensive regulation, put forward more stringent requirements for corporate compliance management.